Our Chief Medical Officer and infectious disease expert, Dr. Mark DiNubile, was recently interviewed for a KYW InDepth podcast. Highlights of the podcast include:
- What happens to our lungs when COVID-19 attacks our bodies and why some people end up in the ICU on ventilators.
- How the naturally-occurring human protein, plasma gelsolin, works in our bodies to fight infection and regulate inflammation.
- What other treatments, like hydroxychloroquine, are being considered for the pandemic.
- Why recombinant human plasma gelsolin should be considered as a treatment for COVID19.
Plasma gelsolin therapy offers promise to abort lung injury, and should be treated as a possible novel therapeutic agent in this time of crisis. We are working diligently to fast track our product and save lives.